期刊文献+

氟非尼酮光聚合产物的确认与检测 被引量:1

Confirmation and quality control of a photoploymerized substance in fluorofenidone
下载PDF
导出
摘要 以固态反应制得氟非尼酮的光聚合产物,使用制备色谱分离纯化,通过UV、MS、13C NMR、1H-1H COSY、HMBC、HMBQ对其进行结构确证。建立反相液相色谱法对光照试验中产生的光聚合产物进行检查。色谱条件为:色谱柱为Kromasil C18柱(4.6 mm×250 mm,5μm),流动相为乙腈-0.1%三乙胺(甲磺酸调pH为4.0)(55∶45),流速为1.0 mL/min,柱温为30℃,检测波长为230 nm。结果表明:氟非尼酮对光敏感,在光照下可产生氟非尼酮的二聚体,本研究所建立的HPLC法可灵敏、准确地检测出该物质。 The solid state reaction was used to prepare a photoploymerized substance from fluorofenidone.The photoploymerized substances were separated and purified by pre-HPLC.The spectral analyses,such as UV,MS,13C NMR,1H-1H COSY,HMBC and HMBQ were used to identify the structure of the photoploymerized substances.The HPLC method was established to determine the photoploymerized substance.The chromatographic conditions were as follows:Kromasil C18 column(4.6 mm×250 mm,5 μm) was used and the column temperature was 30 °C.Acetonitrile-water(55 ∶45) containing 0.1% triethylamine,which was adjusted to pH 4.0 by methanesulfonic acid,was used as the mobile phase with a flow rate of 1.0 mL/min;the detection wavelength was 230 nm.The results showed that fluorofenidone is photosensitive and the method is specific and accurate.
机构地区 中南大学药学院
出处 《中国药科大学学报》 CAS CSCD 北大核心 2012年第2期159-163,共5页 Journal of China Pharmaceutical University
基金 国家"重大新药创制"科技重大专项资助项目(No.2009ZX09102-011)~~
关键词 氟非尼酮 光聚合产物 合成 结构确证 质量控制 fluorofenidone photoploymerized substance synthesis characterization qualtity control
  • 相关文献

参考文献7

  • 1Wang LH,Liu JS,Ning WB,et al.Fluorofenidone attenuates dia-betic nephropathy and kidney fibrosis in db/db mice[J].Phar-macology,2011,88(1/2):88-99. 被引量:1
  • 2Hauber HP,Blaukovitsch M.Current and future treatment optionsin idiopathic pulmonary fibrosis[J].Inflamm Allergy DrugTargets,2010,9(3):158-172. 被引量:1
  • 3Raghu G,Johnson WC,Lockhart D,et al.Treatment of idiopathicpulmonary fibrosis with a new antifibrotic agent,pirfenidone:results of a prospective,open-label Phase II study[J].Am JRespir Crit Care Med,1999,159(4 Pt 1):1 061-1 069. 被引量:1
  • 4Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia:part2(中华人民共和国药典:二部)[S].Beijing:China MedicalScience Press,2010:appendices 204-206. 被引量:1
  • 5ICH Steering Committee.Harmonised Tripartite Guideline(ICH三方协调指导原则)[M].Beijing:People's Medical PublishingHouse,2007:99-111. 被引量:1
  • 6Sieburth SM,McGee KF Jr.Solvent-dependent stereoselectivity ofbis-2-pyridone[4+4] photocycloaddition is due to H-bondeddimers[J].Org Lett,1999,1(11):1 775-1 777. 被引量:1
  • 7Kohmoto S,Noguchi T,Masu H,et al.Reaction-phase-selectiveinter-and intramolecular photochemical reaction of 2-pyridonederivatives[J].Org Lett,2004,6(5):683-685. 被引量:1

同被引文献27

  • 1TAWynn.Cellular and molecular mechanisms of fibrosis[J]J Pathol,2007(2). 被引量:3
  • 2Ling Huang,Fangfang Zhang,Yiting Tang,Jiao Qin,Yu Peng,Lin Wu,Fang Wang,Qiongjing Yuan,Zhangzhe Peng,Jishi Liu,Jie Meng,Lijian Tao.Fluorofenidone Attenuates Inflammation by Inhibiting the NF-кB Pathway[J]. The American Journal of the Medical Sciences . 2014 (1) 被引量:1
  • 3Jiao Qin,Yan‐yun Xie,Ling Huang,Qiong‐jing Yuan,Wen‐Juan Mei,Xiang‐ning Yuan,Gao‐yun Hu,Guang‐jie Cheng,Li‐jian Tao,Zhang‐zhe Peng.Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis[J]. Nephrology . 2013 (10) 被引量:1
  • 4David Gvaramia,Marjolein E. Blaauboer,Roeland Hanemaaijer,Vincent Everts.Role of caveolin-1 in fibrotic diseases[J]. Matrix Biology . 2013 被引量:1
  • 5Yu Peng,Huixiang Yang,Tingting Zhu,Menghua Zhao,Yuexia Deng,Bin Liu,Hong Shen,Gaoyun Hu,Zhaohe Wang,Lijian Tao.The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways[J]. Eur J Clin Invest . 2013 (4) 被引量:1
  • 6Yuan, Qiongjing,Wang, Rui,Peng, Yu,Fu, Xiao,Wang, Wei,Wang, Linghao,Zhang, Fangfang,Peng, Zhangzhe,Ning, Wangbin,Hu, Gaoyun,Wang, Zhaohe,Tao, Lijian.Fluorofenidone Attenuates Tubulointerstitial Fibrosis by Inhibiting TGF-[beta]1-Induced Fibroblast Activation[J]. EN . 2011 (2) 被引量:1
  • 7Wang-bin Ning,Gao-yun Hu,Zhang-zhe Peng,Ling Wang,Wei Wang,Ji-ying Chen,Xuan Zheng,Jing Li,Li-jian Tao.Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas/FasL pathway[J]. International Immunopharmacology . 2011 (9) 被引量:1
  • 8Pitchai Balakumar,Mandeep Kumar Arora,Jayarami Reddy,Madhu B Anand-Srivastava.Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism[J]. Journal of Cardiovascular Pharmacology . 2009 (2) 被引量:1
  • 9Yuan Q,Wang L,Zhang F,et al.Fluorofenidone suppressesepithelial-mesenchymal transition and the expression of connectivetissue growth factor via inhibiting TGF-beta/Smads signaling inhuman proximal tubular epithelial cells. Pharmazie . 2011 被引量:1
  • 10Friedman Scott L,Sheppard Dean,Duffield Jeremy S,Violette Shelia.Therapy for fibrotic diseases: nearing the starting line. Science translational medicine . 2013 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部